Zobrazeno 1 - 5
of 5
pro vyhledávání: '"NV118"'
Autor:
Vlad Florian Avram, Anca Mihaela Bîna, Alexandra Sima, Oana Maria Aburel, Adrian Sturza, Ovidiu Burlacu, Romulus Zorin Timar, Danina Mirela Muntean, Eskil Elmér, Octavian Marius Crețu
Publikováno v:
Life, Vol 11, Iss 4, p 288 (2021)
Diabetes mellitus (DM) is the most severe metabolic disease that reached the level of a global pandemic and is associated with high cardiovascular morbidity. Statins are the first–line lipid–lowering therapy in diabetic patients with or without a
Externí odkaz:
https://doaj.org/article/5996aa97fbec4e69b58e2cb3e30a86fc
Cell-Permeable Succinate Rescues Mitochondrial Respiration in Cellular Models of Amiodarone Toxicity
Autor:
Bețiu, Alina M., Chamkha, Imen, Gustafsson, Ellen, Meijer, Elna, Avram, Vlad F., Frostner, Eleonor Åsander, Ehinger, Johannes K., Petrescu, Lucian, Muntean, Danina M., Elmér, Eskil
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 11786, p 11786 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences
Volume 22
Issue 21
Amiodarone is a potent antiarrhythmic drug and displays substantial liver toxicity in humans. It has previously been demonstrated that amiodarone and its metabolite (desethylamiodarone, DEA) can inhibit mitochondrial function, particularly complexes
Autor:
Romulus Timar, Oana M. Aburel, Eskil Elmér, Adrian Sturza, Ovidiu Burlacu, Vlad Florian Avram, Danina Muntean, Octavian M. Crețu, Alexandra Sima, Anca Mihaela Bîna
Publikováno v:
Life
Volume 11
Issue 4
Life, Vol 11, Iss 288, p 288 (2021)
Volume 11
Issue 4
Life, Vol 11, Iss 288, p 288 (2021)
Diabetes mellitus (DM) is the most severe metabolic disease that reached the level of a global pandemic and is associated with high cardiovascular morbidity. Statins are the first–line lipid–lowering therapy in diabetic patients with or without a
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 1
Volume 22
Issue 1
Statins are the cornerstone of lipid-lowering therapy. Although generally well tolerated, statin-associated muscle symptoms (SAMS) represent the main reason for treatment discontinuation. Mitochondrial dysfunction of complex I has been implicated in
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.